Filing Details
- Accession Number:
- 0000899243-20-035405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 21:39:20
- Reporting Period:
- 2020-12-24
- Accepted Time:
- 2020-12-28 21:39:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1817388 | D. Kenneth Knight | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-24 | 3,622 | $50.50 | 308,027 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on September 9, 2020.
- Includes an aggregate of 283,878 shares of common stock issuable pursuant to restricted stock units that have not vested.